BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo
Market statusData NSENot investment advice
KRISHNA INST OF MED SCI L

KRISHNA INST OF MED SCI L Latest Share Price (KIMS)

NSE: KIMSBSE 543308HealthcareHospitalwww.kimshospitals.com
₹795.60
27.80+3.62%
Overall Score28/100
Day range761
₹795.60
802
52-week576
₹795.60
858
Above low+38.2%
Below high7.3%
Range position78%
Open764.35
Prev Close767.80
Bid795.56417
Ask795.64261

TODAY IN ONE LINE

KIMS jumped 3.6% on average volume, outperforming Nifty's 1.1% move, with no exchange filing today, suggesting a market-driven move.

With a market cap of ₹33,228.81 Cr., it trades at a P/E of 154.20. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume1.0M+132%vs 20D avg
Price Band20
Lower Band534.85
Upper Band802.25
Tick Size0.05
Daily Volatility1.89%
Annualised Vol36.11%
Market Cap₹33,228.81 Cr.
Promoter32.66%
Face Value₹2
Fwd P/E47.01
PEG29.4
EV/EBITDA32.15
P/S8.34
ROA4.81%
Beta0.65
Div Payout—
THE STOCK SCORE
Overall Score28/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

KRISHNA INST OF MED SCI L flags & news 

Key strengths, potential risks, and recent updates.

✅ 4 green flags🚩 3 red flags

Green Flags

  • ●Quarterly OutperformanceLatest quarter Sales up 14.0% and Profit up 99.5%
  • ●Healthy Operating MarginsOPM is structurally strong at 25.4%
  • ●Promoter BuyingPromoters increased holdings by 0.16% QoQ
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • ●Earnings DeclineEPS (TTM) has contracted by 58.3% YoY
  • ●Expensive ValuationTrading at a high P/E ratio of 137.7x
  • ●Rising Receivables vs SalesReceivables grew 47.4% outpacing sales growth of 21.5%

Latest KRISHNA INST OF MED SCI L News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

KRISHNA INST OF MED SCI L valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for KRISHNA INST OF MED SCI L, framed against the sector median so the premium or discount is obvious at a glance.

KRISHNA INST OF MED SCI L trades at a P/E of 154.20× and P/B of 8.11×, against the Healthcare sector median P/E of 49.50×.

Key MetricsMarket + reported · 20 Nov 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹33,228.81 Cr.
P/E Ratio
154.2
P/B Ratio
8.11
EPS
₹1.79
Profitability

Profitability

ROE
10.73%
ROCE
8.27%
Net Margin
6.18%
Op Margin
25.35%
Growth

Growth

EPS YoY
-58.3%
Revenue YoY
34.8%
Qtr Sales
13.98%
Qtr Profit
99.47%
Financial Health

Financial Health

Debt / Equity
0.6
Book Value
₹60.92
Div Yield
—
Promoter Holding
32.66%
Technicals

KRISHNA INST OF MED SCI L technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for KRISHNA INST OF MED SCI L — derived from the latest tape, not yesterday's close.

KRISHNA INST OF MED SCI L last traded at ₹795.6 with an intraday range of ₹760.7–₹801.5 — latest indicator, pivot and CPR signals below.

Last updated: 22 November 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹795.60
LevelPrice (₹)Distance% Δ
R4892.77+97.17+12.21%
R3851.97+56.37+7.08%
R2826.73+31.13+3.91%
R1811.17+15.57+1.96%
PIVOT785.93-9.67-1.22%
CURRENT795.60——
S1770.37-25.23-3.17%
S2745.13-50.47-6.34%
S3729.57-66.03-8.30%
S4688.77-106.83-13.43%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 781.10P: 785.93TC: 790.77
R1
R2
R3
R4
indicator
LTP: 795.60
PDH: 770.00
PDL: 754.05
● Market Sentiment

KIMS is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: ₹760.7–₹785.4

● Price Position

Trading Above opening range, showing Bullishness

Financials

KRISHNA INST OF MED SCI L financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for KRISHNA INST OF MED SCI L — consolidated or standalone — with margins, YoY growth and key ratios inline.

KRISHNA INST OF MED SCI L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹33,228.81 Cr. and reported EPS of ₹1.79.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026May 2026
Revenue from Operations3,905
3,905
▲ 0.0%
Sales Growth YoY %Derived28.65%
28.65%
Other Income26
26
▲ 0.0%
Total Income3,931
3,931
▲ 0.0%
809
809
▲ 0.0%
Gross ProfitDerived3,096
3,096
▲ 0.0%
Gross Margin %Derived79.28%
79.28%
2,294
2,294
▲ 0.0%
EBITDA (Operating Profit)Derived802
802
▲ 0.0%
OPM %Derived20.54%
20.54%
475
475
▲ 0.0%
Profit Before Tax (PBT)331
331
▲ 0.0%
92
92
▲ 0.0%
Effective Tax %Derived27.74%
27.74%
Total Profit for Period242
242
▲ 0.0%
Less: Non-controlling Interests1
1
▲ 0.0%
Net Profit (Owner's PAT)Derived241
241
▲ 0.0%
Net Profit Margin %Derived6.18%
6.18%
PAT Growth YoY %Derived-37.22%
-37.22%
Earnings Per Share (EPS ₹)6.03
6.03
▲ 0.0%
Diluted Shares Outstanding (Cr)40
40
▲ 0.0%
Share of Profit from Associates/JVs3
3
▲ 0.0%
Other Comprehensive Income (Net of Tax)0
0
▲ 0.0%
Total Expenses (incl. D&A & Interest)3,600
3,600
▲ 0.0%
Material Cost % of RevenueDerived—
—
Employee Cost % of RevenueDerived17.46%
17.46%
Other Cost % of RevenueDerived41.28%
41.28%
Interest Coverage (x)Derived2.56x
2.56x
Sales CAGR · 3Y
+8.8%
Sales CAGR · 5Y
+9.3%
PAT CAGR · 3Y
-14.4%
PAT CAGR · 5Y
-4.9%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

KRISHNA INST OF MED SCI L segment analysis : revenue and profit mix.

Disclosed business segments at KRISHNA INST OF MED SCI L with their share of revenue and profit, switchable between consolidated and standalone reporting.

KRISHNA INST OF MED SCI L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for KRISHNA INST OF MED SCI L.

Our AI distills the core fundamental drivers supporting KRISHNA INST OF MED SCI L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 200 (~4.0× the sector multiple of 49.5) would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.10. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 8% would indicate weaker capital compounding.

Shareholding

KRISHNA INST OF MED SCI L shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in KRISHNA INST OF MED SCI L — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

Promoters32.66%↑0.16%
DII33.22%↓1.21%
FII15.01%↑0.27%
Public19.11%↑0.78%

Ownership Distribution

Promoters
32.66%
Domestic Institutions
33.22%
Foreign Institutions
15.01%
Retail & Public
19.11%

Category Trends

Foreign Institutions Breakdown
Total Holding: 15.01%
Net Change: +0.27%
Category Total15.01%
Total Holding15.01%
Net Change+0.27%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 4.80%, but category aggregate is 15.01%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
Amansa Holdings Private Limited
2.15%
0.09%
-0.09%
Sep 2026
Nomura India Investment Fund Mother Fund
1.42%
0.08%
-0.08%
Sep 2026
Polar Capital Funds Plc - Healthcare Opportunities Fund
1.23%
1.23%
+1.23%
Sep 2026
Emerald Investments Limited
0.00%
0.00%
0.00%
Sep 2026
Government Pension Fund Global
0.00%
0.00%
0.00%
Sep 2026
General Atlantic Singapore KH Pte. Ltd.
0.00%
0.00%
0.00%
Sep 2026
Peers

KRISHNA INST OF MED SCI L peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — KRISHNA INST OF MED SCI L is highlighted for quick read-across.

09 · Chart Patterns

KRISHNA INST OF MED SCI L chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for KRISHNA INST OF MED SCI L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

KRISHNA INST OF MED SCI L delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for KRISHNA INST OF MED SCI L over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in KRISHNA INST OF MED SCI L stood at 56.5% of traded volume, against a 20-day average of 58.0%.

Avg Delivery (20D)58%-1.5 ppt latest vs avg
Highest Delivery84.7%on 06 Nov
Avg Volume (20D)4.50 L20-day run-rate
Conviction Trend↓ Weakening-1.5 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

KRISHNA INST OF MED SCI L announcements: results, concalls, ratings, M&A.

Filings KRISHNA INST OF MED SCI L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

KRISHNA INST OF MED SCI L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 200 documents below.

  1. 14 Nov 2026OthersView PDF

    Others

    Krishna Institute of Medical Sciences Limited has informed the Exchange about O & M Agreement

  2. 11 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript

  3. 10 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet

  4. 10 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet

  5. 05 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Krishna Institute of Medical Sciences Limited has informed the Exchange about Link of Recording

Corporate Actions

KRISHNA INST OF MED SCI L dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue KRISHNA INST OF MED SCI L has declared, sequenced by announce and record date.

KRISHNA INST OF MED SCI L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About KRISHNA INST OF MED SCI L: business, sector, key facts.

What KRISHNA INST OF MED SCI L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

KRISHNA INST OF MED SCI L operates in the Hospital industry under the Healthcare sector, listed as NSE: KIMS, BSE: 543308.

KIMS
Healthcare

KRISHNA INST OF MED SCI L

NSE · KIMS·BSE · 543308·www.kimshospitals.com

KIMS Hospitals, officially Krishna Institute of Medical Sciences Limited, is a prominent healthcare provider in India, operating under the KIMS Hospitals brand. Their business centers on delivering a comprehensive range of medical and healthcare services across numerous specialties. This wide-ranging approach allows them to cater to a diverse patient population with varied healthcare needs.

The company's service offerings span a broad spectrum of medical disciplines. Key specialties include cardiology, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgery. Beyond these core areas, KIMS also provides services in gastroenterology and hepatology, heart and lung transplants, other organ transplantation procedures, mother and childcare, and pediatrics. This comprehensive approach ensures a wide array of patient needs can be addressed within their facilities.

Further specializing their services, KIMS focuses on areas such as accident and emergency care, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, and Alzheimer's disease management. They also possess expertise in various specialized centers, including bone and joint centers. This detailed specialization allows for targeted expertise and advanced treatment options in specific medical fields.

The breadth of their procedural capabilities is equally impressive. KIMS performs a wide variety of medical procedures, including those related to aneurysms, ankle arthritis and replacements, cervical discectomies and fusions, anterior resections, aortic aneurysms and stent grafts, aortic valve replacements, arthroscopies, atrial septal defects, and bariatric surgeries. This extensive procedural capacity demonstrates a high level of technological and surgical proficiency.

Established in 1973 and headquartered in Secunderabad, India, KIMS Hospitals has a long history of providing healthcare services within the country. Their continued growth and expansion into diverse medical specialties highlights their commitment to providing advanced and comprehensive healthcare solutions to the Indian population.

company facts
Employees—
SectorHealthcare
HeadquartersSecunderabad, India
Market Cap₹33,228.81 Cr.
Listed OnNSE
leadership20 on record
Dr. Abhinay Bollineni
Chief Executive Officer, Executive Director
Dr. Abhinay Bollineni
CEO & Executive Director
Dr. Bhaskara Bollineni
Executive Chairman of the Board, Managing Director
Dr. Bhaskara Rao Bollineni
Founder, MD & Executive Chairman
Dr. Juttur Raghavendradas Nagajayanthi
Company Secretary, Compliance Officer & General Counsel
Dr. Nagajayanthi Das
Company Secretary and Compliance Officer
Dr. Nitish Shetty
CEO for KIMS Bangalore Cluster
Dr. Saumen Chakraborty
Non-Executive Independent Director
Mr. Adwik Bollineni
Non-Executive Non-Independent Director
Mr. Adwik Bollineni
Executive Director
Mr. Bhaskar Reddy R. K
Chief Risk Officer & Chief Internal Audit
Mr. Ratna Kaza
Non-Executive Independent Director
§ ∞ · Plainly Answered

Questions investors ask about KRISHNA INST OF MED SCI L (KIMS).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of KRISHNA INST OF MED SCI L (KIMS)?

The current share price of KRISHNA INST OF MED SCI L (KIMS) is ₹795.60. Today, the stock has gained by ₹27.80 (3.62%), trading in a range of ₹760.70 to ₹801.50. The stock opened at ₹764.35 with a trading volume of 10,43,606 shares.

02Is KRISHNA INST OF MED SCI L stock a good investment for long-term?

KRISHNA INST OF MED SCI L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹33,228.81 Cr., P/E ratio of 154.2, ROE of 10.73%, and ROCE of 8.27%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of KRISHNA INST OF MED SCI L stock?

The 52-week high price of KRISHNA INST OF MED SCI L (KIMS) is ₹858.00, while the 52-week low is ₹575.80. Currently trading at ₹795.60, the stock is 38.17% above its 52-week low and 7.27% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy KRISHNA INST OF MED SCI L stock at the current price?

Whether to buy KRISHNA INST OF MED SCI L stock at ₹795.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 154.2 and P/B ratio of 8.11. Today's performance shows a gain of 3.62%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of KRISHNA INST OF MED SCI L and when is the next dividend?

KRISHNA INST OF MED SCI L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹795.60, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of KRISHNA INST OF MED SCI L?

KRISHNA INST OF MED SCI L's key financial metrics include: P/E Ratio: 154.2, P/B Ratio: 8.11, ROE: 10.73%, ROCE: 8.27%, Dividend Yield: 0%, EPS: ₹1.79, Book Value: ₹60.92, and Debt-to-Equity: 0.6. The company's market cap stands at ₹33,228.81 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is KRISHNA INST OF MED SCI L stock performing today in the market?

KRISHNA INST OF MED SCI L stock opened at ₹764.35 and is currently trading at ₹795.60, showing a gain of ₹27.80 (3.62%). The intraday high is ₹801.50 and low is ₹760.70. The trading volume stands at 10,43,606 shares, indicating strong market participation today.

08What is the P/E ratio of KRISHNA INST OF MED SCI L and what does it indicate?

KRISHNA INST OF MED SCI L has a Price-to-Earnings (P/E) ratio of 154.2, which means investors are willing to pay 154.20 for every ₹1 of earnings. With an EPS of ₹1.79, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about KRISHNA INST OF MED SCI L (KIMS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.